The Implications of Combined Hormonal Contraceptives in Cancer

Abstract

1.Background/Objectives: Combined hormonal contraceptives (CHCs) are widely used by women during their fertile years. Often, these pills are taken without medical advice, which can lead to certain unwanted effects. This class of medication has been studied over the years for its impact on various types of cancer. Since cancer is becoming an increasingly common condition, understanding the factors that contribute to its development is important for prevention. 2. Methods: This paper reviews recent literature from reputable sources such as PubMed, Google Scholar, ScienceDirect, and Scopus. 3. Results: The review of the medical literature reported evidence about the risk of CHCs in developing breast and cervical cancer, and more, about the protective effect on ovarian, endometrial, and colorectal cancer. 4. Conclusion: This paper presents the risk/benefit balance of CHCs in terms of their impact on some cancerous pathologies. According to the analysis, we can state that CHCs are effective and even safe if administered appropriately and according to the recommendations of specialists, depending on the particularities of each patient.